Google
×
AllImagesVideosNews Maps Shopping Books
Search tools
Past year
  • Recent
  • Past hour
  • Past 24 hours
  • Past week
  • Past month
  • Past year
  • Archives
Sorted by relevance
Clear

Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis

Nature
The development of disease-modifying therapies (DMTs) for neurological disorders is an important goal in modern neurology, and the associated challenges are...
1 month ago

Disease-Modifying Research Pipeline Holds Possibility for Parkinson’s

Parkinson's Foundation
Research is at the beginning stages of discovering disease-modifying therapies that might slow or stop the loss of dopamine-producing neurons.
6 months ago

Disease-Modifying Therapies for MS

National Multiple Sclerosis Society
Research shows early and ongoing treatment with an approved DMT can help reduce MS relapses, delay progression of disability and limit new inflammation.
7 months ago

How Common Is ONJ Caused by Bone-Modifying Drugs?

National Cancer Institute (.gov)
About 9% of people with metastatic breast cancer taking drugs like denosumab (Xgeva) and zoledronic acid developed jaw osteonecrosis, a new study finds.
2 months ago

Modifying homes for stroke survivors saves lives, extends independence – WashU Medicine

WashU Medicine
Louis has found that modifications to stroke survivors' homes – such as grab bars, shower seats, ramps and other safety interventions – reduce the risk of death...
1 month ago

Role of Polyunsaturated Fat in Modifying Cardiovascular Risk Associated With Family History of Cardiovascular Disease: Pooled De Novo Results From 15 Observational Studies | Circulation

American Heart Association Journals
Conclusions. The findings from this study suggest that low blood/tissue levels of n-3 EPA/DHA, reflecting a low intake of fats present in oily fish, may...
11 months ago

Multiplexed mapping of the interactome of GPCRs with receptor activity–modifying proteins

Science | AAAS
We report the GPCR-RAMP interactome for three RAMPs and 215 GPCRs representing all receptor subfamilies. All potential GPCR-RAMP interacting pairs were...
4 months ago

Another Stab at Disease-Modifying OA Drug Hits Home in Early Study

MedPage Today
Taking a page from HIV medicine.
1 month ago

Modifying Choice - by Melissa Purtee - Thoughts on Arting

Substack
I often write about my Studio class, which is almost completely student-directed.
11 months ago

Modifying Naturally Occurring, Nonmammalian-Sourced Biopolymers for Biomedical Applications

ACS Publications
We focus on biopolymers obtained from natural, nonmammalian sources, including silk fibroins, alginates, chitosans, chitins, mucins, keratins, and resilins.
2 months ago